P

Inventor

MAO CAN

US13 patents
⚠️ This page may combine multiple inventors who share the name “MAO CAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOEHRINGER INGELHEIM INT

5 patents
US7879873B2Feb 1, 2011

Azaindazole compounds as CCR1 receptor antagonists

BOEHRINGER INGELHEIM INT22 citations90
US8008327B2Aug 30, 2011

Indazole compounds as CCR1 receptor antagonists

BOEHRINGER INGELHEIM INT8 citations83
US10875852B2Dec 29, 2020

Heteroaromatic compounds as BTK inhibitors

BOEHRINGER INGELHEIM INT2 citations71
US10138229B2Nov 27, 2018

Heteroaromatic compounds as BTK inhibitors

BOEHRINGER INGELHEIM INT2 citations71
US9828364B2Nov 28, 2017

Pyrazole compounds as BTK inhibitors

BOEHRINGER INGELHEIM INT0 citations39

COOK BRIAN NICHOLAS

3 patents
US8063065B2Nov 22, 2011

Azaindazole compounds as CCR1 receptor antagonists

COOK BRIAN NICHOLAS12 citations80
US8293917B2Oct 23, 2012

Pyrazole compounds as CCR1 antagonists

COOK BRIAN NICHOLAS9 citations77
US9056858B2Jun 16, 2015

Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists

COOK BRIAN NICHOLAS0 citations40

KUZMICH DANIEL

2 patents
US8263597B2Sep 11, 2012

Indazole compounds as CCR1 receptor antagonists

KUZMICH DANIEL6 citations82
US8163918B2Apr 24, 2012

Azaindazole compounds as CCR1 receptor antagonists

KUZMICH DANIEL1 citations61

BOEHRINGER INGELHEIM PHAMACEUT

1 patent
US6974870B2Dec 13, 2005

Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses

BOEHRINGER INGELHEIM PHAMACEUT23 citations86

BOEHRINGER INGELHEIM PHARMA

1 patent
US7329764B2Feb 12, 2008

Substitute benzothiophene compounds

BOEHRINGER INGELHEIM PHARMA2 citations60

BETAGERI RAJASHEKHAR

1 patent
US8546442B2Oct 1, 2013

Pyrazolopiperidine compounds as CCR1 receptor antagonists

BETAGERI RAJASHEKHAR0 citations33